Normal Fasting-State Levels of Serum Cholyl-Conjugated Bile Acids in Gilbert's Syndrome: An Aid to the Diagnosis
John M. Vierling
Liver Unit, NIAMDD, NIH, Bethesda, Maryland 20205; the Polly Annenberg Levee Hematology Center, Department of Medicine, Mount Sinai School of Medicine, New York, New York 10029; the Department of Medicine, Albert Einstein College of Medicine, New York, New York 10461; the Division of Gastroenterology, Department of Medicine, Veterans Administration Medical Center and University of Colorado Health Sciences Center, Denver, Colorado 80225; the Division of Gastroenterology, Mayo Clinic and Foundation, Rochester, Minnesota 55455; the Division of Gastroenterology, Department of Medicine, University of California at San Diego, San Diego, California 92093; and the Department of Medicine, University of California Medical Center, San Francisco, California 94143
Search for more papers by this authorCorresponding Author
Paul D. Berk
Liver Unit, NIAMDD, NIH, Bethesda, Maryland 20205; the Polly Annenberg Levee Hematology Center, Department of Medicine, Mount Sinai School of Medicine, New York, New York 10029; the Department of Medicine, Albert Einstein College of Medicine, New York, New York 10461; the Division of Gastroenterology, Department of Medicine, Veterans Administration Medical Center and University of Colorado Health Sciences Center, Denver, Colorado 80225; the Division of Gastroenterology, Mayo Clinic and Foundation, Rochester, Minnesota 55455; the Division of Gastroenterology, Department of Medicine, University of California at San Diego, San Diego, California 92093; and the Department of Medicine, University of California Medical Center, San Francisco, California 94143
Paul D. Berk, M.D., Polly Annenberg Levee Hematology Center, Department of Medicine, Mount Sinai School of Medicine, New York, New York 10029.===Search for more papers by this authorAlan F. Hofmann
Liver Unit, NIAMDD, NIH, Bethesda, Maryland 20205; the Polly Annenberg Levee Hematology Center, Department of Medicine, Mount Sinai School of Medicine, New York, New York 10029; the Department of Medicine, Albert Einstein College of Medicine, New York, New York 10461; the Division of Gastroenterology, Department of Medicine, Veterans Administration Medical Center and University of Colorado Health Sciences Center, Denver, Colorado 80225; the Division of Gastroenterology, Mayo Clinic and Foundation, Rochester, Minnesota 55455; the Division of Gastroenterology, Department of Medicine, University of California at San Diego, San Diego, California 92093; and the Department of Medicine, University of California Medical Center, San Francisco, California 94143
Search for more papers by this authorJames F. Martin
Liver Unit, NIAMDD, NIH, Bethesda, Maryland 20205; the Polly Annenberg Levee Hematology Center, Department of Medicine, Mount Sinai School of Medicine, New York, New York 10029; the Department of Medicine, Albert Einstein College of Medicine, New York, New York 10461; the Division of Gastroenterology, Department of Medicine, Veterans Administration Medical Center and University of Colorado Health Sciences Center, Denver, Colorado 80225; the Division of Gastroenterology, Mayo Clinic and Foundation, Rochester, Minnesota 55455; the Division of Gastroenterology, Department of Medicine, University of California at San Diego, San Diego, California 92093; and the Department of Medicine, University of California Medical Center, San Francisco, California 94143
Search for more papers by this authorAllan W. Wolkoff
Liver Unit, NIAMDD, NIH, Bethesda, Maryland 20205; the Polly Annenberg Levee Hematology Center, Department of Medicine, Mount Sinai School of Medicine, New York, New York 10029; the Department of Medicine, Albert Einstein College of Medicine, New York, New York 10461; the Division of Gastroenterology, Department of Medicine, Veterans Administration Medical Center and University of Colorado Health Sciences Center, Denver, Colorado 80225; the Division of Gastroenterology, Mayo Clinic and Foundation, Rochester, Minnesota 55455; the Division of Gastroenterology, Department of Medicine, University of California at San Diego, San Diego, California 92093; and the Department of Medicine, University of California Medical Center, San Francisco, California 94143
Search for more papers by this authorBruce F. Scharschmidt
Liver Unit, NIAMDD, NIH, Bethesda, Maryland 20205; the Polly Annenberg Levee Hematology Center, Department of Medicine, Mount Sinai School of Medicine, New York, New York 10029; the Department of Medicine, Albert Einstein College of Medicine, New York, New York 10461; the Division of Gastroenterology, Department of Medicine, Veterans Administration Medical Center and University of Colorado Health Sciences Center, Denver, Colorado 80225; the Division of Gastroenterology, Mayo Clinic and Foundation, Rochester, Minnesota 55455; the Division of Gastroenterology, Department of Medicine, University of California at San Diego, San Diego, California 92093; and the Department of Medicine, University of California Medical Center, San Francisco, California 94143
Search for more papers by this authorJohn M. Vierling
Liver Unit, NIAMDD, NIH, Bethesda, Maryland 20205; the Polly Annenberg Levee Hematology Center, Department of Medicine, Mount Sinai School of Medicine, New York, New York 10029; the Department of Medicine, Albert Einstein College of Medicine, New York, New York 10461; the Division of Gastroenterology, Department of Medicine, Veterans Administration Medical Center and University of Colorado Health Sciences Center, Denver, Colorado 80225; the Division of Gastroenterology, Mayo Clinic and Foundation, Rochester, Minnesota 55455; the Division of Gastroenterology, Department of Medicine, University of California at San Diego, San Diego, California 92093; and the Department of Medicine, University of California Medical Center, San Francisco, California 94143
Search for more papers by this authorCorresponding Author
Paul D. Berk
Liver Unit, NIAMDD, NIH, Bethesda, Maryland 20205; the Polly Annenberg Levee Hematology Center, Department of Medicine, Mount Sinai School of Medicine, New York, New York 10029; the Department of Medicine, Albert Einstein College of Medicine, New York, New York 10461; the Division of Gastroenterology, Department of Medicine, Veterans Administration Medical Center and University of Colorado Health Sciences Center, Denver, Colorado 80225; the Division of Gastroenterology, Mayo Clinic and Foundation, Rochester, Minnesota 55455; the Division of Gastroenterology, Department of Medicine, University of California at San Diego, San Diego, California 92093; and the Department of Medicine, University of California Medical Center, San Francisco, California 94143
Paul D. Berk, M.D., Polly Annenberg Levee Hematology Center, Department of Medicine, Mount Sinai School of Medicine, New York, New York 10029.===Search for more papers by this authorAlan F. Hofmann
Liver Unit, NIAMDD, NIH, Bethesda, Maryland 20205; the Polly Annenberg Levee Hematology Center, Department of Medicine, Mount Sinai School of Medicine, New York, New York 10029; the Department of Medicine, Albert Einstein College of Medicine, New York, New York 10461; the Division of Gastroenterology, Department of Medicine, Veterans Administration Medical Center and University of Colorado Health Sciences Center, Denver, Colorado 80225; the Division of Gastroenterology, Mayo Clinic and Foundation, Rochester, Minnesota 55455; the Division of Gastroenterology, Department of Medicine, University of California at San Diego, San Diego, California 92093; and the Department of Medicine, University of California Medical Center, San Francisco, California 94143
Search for more papers by this authorJames F. Martin
Liver Unit, NIAMDD, NIH, Bethesda, Maryland 20205; the Polly Annenberg Levee Hematology Center, Department of Medicine, Mount Sinai School of Medicine, New York, New York 10029; the Department of Medicine, Albert Einstein College of Medicine, New York, New York 10461; the Division of Gastroenterology, Department of Medicine, Veterans Administration Medical Center and University of Colorado Health Sciences Center, Denver, Colorado 80225; the Division of Gastroenterology, Mayo Clinic and Foundation, Rochester, Minnesota 55455; the Division of Gastroenterology, Department of Medicine, University of California at San Diego, San Diego, California 92093; and the Department of Medicine, University of California Medical Center, San Francisco, California 94143
Search for more papers by this authorAllan W. Wolkoff
Liver Unit, NIAMDD, NIH, Bethesda, Maryland 20205; the Polly Annenberg Levee Hematology Center, Department of Medicine, Mount Sinai School of Medicine, New York, New York 10029; the Department of Medicine, Albert Einstein College of Medicine, New York, New York 10461; the Division of Gastroenterology, Department of Medicine, Veterans Administration Medical Center and University of Colorado Health Sciences Center, Denver, Colorado 80225; the Division of Gastroenterology, Mayo Clinic and Foundation, Rochester, Minnesota 55455; the Division of Gastroenterology, Department of Medicine, University of California at San Diego, San Diego, California 92093; and the Department of Medicine, University of California Medical Center, San Francisco, California 94143
Search for more papers by this authorBruce F. Scharschmidt
Liver Unit, NIAMDD, NIH, Bethesda, Maryland 20205; the Polly Annenberg Levee Hematology Center, Department of Medicine, Mount Sinai School of Medicine, New York, New York 10029; the Department of Medicine, Albert Einstein College of Medicine, New York, New York 10461; the Division of Gastroenterology, Department of Medicine, Veterans Administration Medical Center and University of Colorado Health Sciences Center, Denver, Colorado 80225; the Division of Gastroenterology, Mayo Clinic and Foundation, Rochester, Minnesota 55455; the Division of Gastroenterology, Department of Medicine, University of California at San Diego, San Diego, California 92093; and the Department of Medicine, University of California Medical Center, San Francisco, California 94143
Search for more papers by this authorAbstract
Fasting levels of cholic acid conjugates were determined by radioimmunoassay in the serum of 24 patients with extensively documented Gilbert's syndrome and in 98 healthy controls without unconjugated hyperbilirubinemia. The Gilbert's syndrome patients studied included all three subtypes, as determined from studies of the plasma disappearance kinetics of sulf obromophthalein and indocyanine green. Although patients with structural liver disease severe enough to produce hyperbilirubinemia almost invariably have elevated fasting serum levels of cholic acid conjugates, values were normal in each of the Gilbert's syndrome patients, including patients with metabolic abnormalities in sulfobromophthalein and indocyanine green transport. It is concluded that the measurement of fasting serum levels of cholic acid conjugates is a useful adjunct to the diagnosis of Gilbert's syndrome.
References
- 1 Kornberg A. Latent liver disease in persons recovered from catarrhal jaundice and in otherwise normal medical students as revealed by the bilirubin excretion test. J Clin Invest 1942; 21: 299–308.
- 2 Berk PD, Jones EA, Howe RB, et al. Disorders of bilirubin metabolism. In: PK Bondy, L Rosenberg, eds. Metabolic control and disease, 8th edition. Philadelphia: WB Saunders Co., 1979; 1009–1088.
- 3 Bailey A, Robinson D, Dawson AM. Does Gilbert's disease exist? Lancet 1977; 1: 931–933.
- 4 Berk PD, Blaschke TF, Waggoner JG. Defective BSP clearance in patients with constitutional hepatic dysfunction (Gilbert's syndrome). Gastroenterology 1972; 63: 472–481.
- 5 Martin JF, Vierling JM, Wolkoff AW, et al. Abnormal hepatic transport of indocyanine green in Gilbert's syndrome. Gastroenterology 1976; 70: 385–391.
- 6 Simmonds WJ, Korman MG, Go VLW, et al. Radioimmunoassay of conjugated cholyl bile acid in serum. Gastroenterology 1973; 65: 705–711.
- 7 Howe RB, Berk PD, Bloomer JR, et al. Preparation and properties of specifically labeled radiochemically stable 3H-bilirubin. J Lab Clin Med 1970; 75: 499–502.
- 8 Barett PVD, Mullins FX, Berlin NI. Studies on the biosynthetic production of bilirubin-C'4: an improved method utilizing delta-aminolevulinic acid-4−14C in dogs. J Lab Clin Med 1966; 68: 905–912.
- 9 Berk PD, Howe RB, Bloomer JR, et al. Studies of bilirubin kinetics in normal adults. J Clin Invest 1969; 48: 2176–2190.
- 10 Read RC. Studies of red cell volume and turnover using radi-ochromium. Description of a new “closed” method of red cell volume measurement. N Engl J Med 1954; 250: 1021–1027.
- 11 Sterling K, Gray SJ. Determination of the circulating red cell volume in man by radioactive chromium. J Clin Invest 1950; 29: 1614–1619.
- 12 Berk PD, Bloomer JR, Howe RB, et al. Constitutional hepatic dysfunction (Gilbert's syndrome): a new definition based on kinetic studies with unconjugated radiobilirubin. Am J Med 1970; 49: 296–305.
- 13 Berk PD, Blaschke TF. Detection of Gilbert's syndrome in patients with hemolysis, using radioactive chromium. Ann Intern Med 1972; 77: 527–531.
- 14 Barth RF, Grimley PM, Berk PD, et al. Excess lipofuscin accumulation in constitutional hepatic dysfunction (Gilbert's syndrome). Arch Pathol 1971; 91: 41–47.
- 15 Black M, Billing BH. Hepatic bilirubin UDP glucuronyl transferase activity in liver disease and Gilbert's syndrome. N Engl J Med 1969; 280: 1266–1271.
- 16 Lindner H. Grenzen and Gefahren der perkutanen Leberbiopsie mit der Menghini-Nadel: Erfahrungen bei 80,000 Leberbiopsien. Deutsch Med Wschr 1967; 92: 1751–1757.
- 17
Anonymous.
Gilbert's syndrome.
Br Med J
1968;
2:
256.
10.1136/bmj.2.5600.256 Google Scholar
- 18 Foulk WT, Butt HR, Owen CA, et al. Constitutional hepatic dysfunction (Gilbert's disease): its natural history and related syndromes. Medicine 1959; 38: 25–46.
- 19 Jones EA, Berk PD. Liver function. In: SS Brown, FL Mitchell, DS Young, eds. Chemical diagnosis of disease, Chap 10. Amsterdam: Elsevier, 1979: 525–662.
- 20 Kaplowitz N, Kok E, Javitt NB. Postprandial serum bile acid for the detection of hepatobiliary disease. JAMA 1973; 225: 292–293.
- 21 Korman MG, Hofmann AF, Summerskill WHJ. Assessment of activity in chronic active liver disease. Serum bile acids compared with conventional tests and histology. N Engl J Med 1974; 290: 1399–1402.
- 22 Douglas JG, Beckett GJ, Nimmo IA, et al. Clinical value of bile salt tests in anicteric liver disease. Gut 1981; 22: 141–148.
- 23 Javitt NB. Diagnostic value of serum bile acids. Clin Gastroenterol 1977; 6: 219–226.
- 24 Mazzella G, Roda A, Roda E, et al. Bile acids in Gilbert's syndrome. Ital J Gastroenterol 1978; 10 (Suppl 1): 65.
- 25 Neale G, Lewis B, Weaver V, et al. Serum bile acids in liver disease. Gut 1971; 12: 145–152.
- 26 Barnes S, Gallo GA, Trash DB, et al. Diagnostic value of serum bile acid estimations in liver disease. J Clin Pathol 1975; 28: 506–509.
- 27 Ohkubo H, Okuda K, Iida S, et al. Ursodeoxycholic acid oral tolerance test in patients with constitutional hyperbilirubinemias and effect of phenobarbital. Gastroenterology 1981; 81: 126–135.
- 28 Nambu M, Namihisa T, Yamashiro Y, et al. Plasma disappearance of serum bile acids in patients with constitutional hyperbilirubinemia and constitutional ICG excretory defect. Jap J Gastroenterol 1980; 77: 1369–1377.
- 29 Reichen J, Paumgartner G. Uptake of bile acids by the isolated perfused rat liver. Am J Physiol 1976; 231: 734–742.
- 30 Scharschmidt BF, Stephens JE. Transport of sodium, chloride, and taurocholate by cultured rat hepatocytes. Proc Natl Acad Sci 1981; 78: 986–990.
- 31 Anwer MS, Hegner D. Effect of Na+ on bile acid uptake by isolated rat hepatocytes. Evidence for a heterogeneous system. Hoppe-Seyler's Z Physiol Chem 1978; 359: 181–192.
- 32 Anwer MS, Hegner D. Effect of organic anions on bile acid uptake by isolated rat hepatocytes. Hoppe-Seyler's Z Physiol Chem 1978; 359: 1027–1030.
- 33 Engelking LR, Gronwall R. Bile acid clearance in sheep with hereditary hyperbilirubinemia. Am J Vet Res 1979; 40: 1277–1280.
